Merck & Co., Inc.
147.53USD
-0.9300 (-0.63%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.21▼ | $2.31 | 1 | 9 |
| Next quarter | $1.96▲ | $1.86 | 3 | 8 |
| Current year | $2.75▲ | $2.74 | 11 | 4 |
| Next year | $9.55▼ | $9.56 | 7 | 10 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.26 | $-0.13 | +0.13 (+49.4%) |
| 2026-03-31 | $-1.47 | $-1.28 | +0.19 (+13.2%) |
| 2025-12-31 | $2.01 | $2.04 | +0.03 (+1.5%) |
| 2025-09-30 | $2.35 | $2.58 | +0.23 (+9.9%) |
368 ratings from 39 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Leerink Partners | Maintained | Outperform | $127 $161 | Sep 9, 2026 |
| Guggenheim | Maintained | Buy | $146 $170 | Sep 8, 2026 |
| Wells Fargo | Maintained | Overweight | $150 $170 | Sep 4, 2026 |
| Wolfe Research | Maintained | Outperform | $155 $180 | Aug 25, 2026 |
| Argus Research | Maintained | Buy | $145 $170 | Aug 25, 2026 |
| Goldman Sachs | Maintained | Buy | $140 $160 | Aug 21, 2026 |
| BMO Capital | Maintained | Outperform | $142 $170 | Aug 20, 2026 |
| UBS | Maintained | Buy | $145 $175 | Aug 20, 2026 |
| RBC Capital | Downgraded from Outperform | Sector Perform | $142 $150 | Aug 20, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $116 $179 | Aug 20, 2026 |
| Daiwa Capital | Upgraded from Neutral | Outperform | $120 $143 | Aug 12, 2026 |
| Argus Research | Maintained | Buy | $130 $145 | Aug 11, 2026 |
| Guggenheim | Maintained | Buy | $145 $146 | Aug 5, 2026 |
| Barclays | Maintained | Overweight | $140 $150 | Jul 29, 2026 |
| JP Morgan | Maintained | Overweight | $135 $140 | Jul 13, 2026 |
| BMO Capital | Maintained | Outperform | $135 $142 | Jul 13, 2026 |
| Guggenheim | Maintained | Buy | $140 $145 | Jul 13, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $112 $113 | Jul 9, 2026 |
| RBC Capital | Reiterated | Outperform | $142 | Jul 8, 2026 |
| Wells Fargo | Maintained | Overweight | $145 $150 | Jul 8, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $120 | Jul 6, 2026 |
| B of A Securities | Maintained | Buy | $130 $141 | Jun 30, 2026 |
| Scotiabank | Maintained | Sector Outperform | $136 $155 | Jun 30, 2026 |
| CICC | Initiated | Outperform | $138 | Jun 24, 2026 |
| Wells Fargo | Maintained | Overweight | $150 $145 | May 1, 2026 |
78 filings from 16 insiders · 16 buy / 7 sell over 6m
Officers and directors of MRK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| GUINDO CHIRFIOfficer | Sell | 10.0k | $135.00 | $1.35M | Aug 13, 2026 |
| ZACHARY JENNIFER LGeneral Counsel | Sell | 80.3k | $133.46 | $10.72M | Aug 12, 2026 |
| DELUCA RICHARD ROBERT JR.Officer | Sell | 45.3k | $130.43 | $5.94M | Aug 12, 2026 |
| ZACHARY JENNIFER LGeneral Counsel | Exercise | 54.9k | $84.71 | $6.03M | Aug 12, 2026 |
| GUINDO CHIRFIOfficer | Sell | 15.0k | $131.00 | $1.97M | Aug 6, 2026 |
| DELUCA RICHARD ROBERT JR.Officer | Sell | 6.0k | $130.23 | $789k | Aug 6, 2026 |
| MARALDO DAVID R.Officer | Sell | 18.7k | $128.72 | $2.41M | Aug 5, 2026 |
| WILLIAMS DAVID MICHAELChief Technology Officer | Sell | 52.8k | $128.77 | $6.81M | Aug 5, 2026 |
| WILLIAMS DAVID MICHAELChief Technology Officer | Exercise | 52.8k | $73.73 | $3.94M | Aug 5, 2026 |
| MARALDO DAVID R.Officer | Exercise | 18.7k | $73.73 | $1.54M | Aug 5, 2026 |
| SMART DALTON E. IIIOfficer | Exercise | 383 | $112.16 | $43k | May 1, 2026 |
| MARALDO DAVID R.Officer | Exercise | 552 | $112.16 | $62k | May 1, 2026 |
| SMART DALTON E. IIIOfficer | Exercise | 1.4k | $110.03 | $155k | Apr 30, 2026 |
| LARSON BETTY DOfficer | Other | 13.4k | — | — | Apr 30, 2026 |
| WILLIAMS DAVID MICHAELChief Technology Officer | Other | 1.4k | — | — | Apr 29, 2026 |
| LITCHFIELD CAROLINEChief Financial Officer | Other | 3.9k | — | — | Apr 29, 2026 |
| ZACHARY JENNIFER LGeneral Counsel | Other | 3.0k | — | — | Apr 29, 2026 |
| LI DEAN YOfficer | Other | 4.7k | — | — | Apr 29, 2026 |
| OOSTHUIZEN JOHANNES JACOBUSOfficer | Other | 1.4k | — | — | Apr 29, 2026 |
| DELUCA RICHARD ROBERT JR.Officer | Other | 2.5k | — | — | Apr 29, 2026 |
No analyst notes on MRK yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 15 | 8 | 0 | 0 | Buy2.11 |
| 1 mo ago | 5 | 15 | 8 | 0 | 0 | Buy2.11 |
| 2 mo ago | 4 | 15 | 8 | 0 | 1 | Buy2.25 |
| 3 mo ago | 4 | 15 | 9 | 0 | 1 | Buy2.28 |